Skip to content

Analysis of submucosal microbiome and nonsurgical treatment outcomes of peri-implant diseases in reconstructed jaws

Analysis of submucosal microbiome and nonsurgical treatment outcomes of peri-implant diseases in reconstructed jaws

Status
Recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069029
Enrollment
Unknown
Registered
2023-03-04
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peri-implant disease

Interventions

experimental group :glycine subgingival air polishing
Control group:N/A
Peri-implant health group:N/A
Peri-implant mucositis group:N/A
Peri-implant inflammation group:N/A

Sponsors

Department of Periodontology, Peking University School and Hospital of Stomatology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Part One of the Study Participants of the study: Patients who underwent jaw reconstruction surgery due to tumors in the Department of Oral and Maxillofacial Surgery at Peking University School and Hospital of Stomatology and completed implant restoration between January 2020 and December 2022. Inclusion criteria: 1. Age: 18-70 years old. 2. Implants in the jaw reconstruction area using either fibula or iliac crest graft have completed restoration for at least 3 months. Part Two of the Study Participants of the study: Patients who underwent jaw reconstruction surgery due to tumors in the Department of Oral and Maxillofacial Surgery at Peking University School and Hospital of Stomatology and completed implant insertion between January 2023 and December 2024. Inclusion criteria: 1. Age: 18-70 years old. 2. Implants in the mandibular reconstruction area using either fibula or iliac crest graft have been inserted for 3 months. 3. Radiographs show the implant has good osseointegration, and the bone absorption around the implant is less than half of the implant length.

Exclusion criteria

Exclusion criteria: Part One of the Study Exclusion criteria: 3. Refusing to participate in the study. 4. Having Received radiation or chemotherapy, or being unable to complete follow-up treatment due to disease recurrence. 5. Having Received mechanical debridement or antibiotic treatment in the past three months. 6. Heavy smoker (more than 10 cigarettes per day). 7. Suffering from systemic diseases such as uncontrolled diabetes or hypertension, upper respiratory tract infection. Part Two of the Study Exclusion criteria: Same as Part One.

Design outcomes

Primary

MeasureTime frame
probing depth;bleeding index;inflammatory cytokine level in peri-implant crevicular fluid;Bacterial diversity of peri-implant plaque;

Secondary

MeasureTime frame
modified plaque index;keratinized mucosa width;mucosal thickness;marginal bone loss;

Countries

China

Contacts

Public ContactLu Ruifang

Peking University School and Hospital of Stomatology

kqrflu@bjmu.edu.cn13811507491

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026